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Background: Recent human and animal studies suggest that gut microbes can influence atherosclerosis via generation of
trimethylamine N-oxide (TMAO).
Results: Cecal microbial transplantation from atherosclerosis-prone versus -resistant inbred strains of mice transmitted
enhanced choline diet-dependent atherosclerosis and TMAO levels.
Conclusion: Atherosclerosis susceptibility can be transmitted with gut microbial transplantation.
Significance: Gut microbes participate in atherosclerosis susceptibility and are thus a potential therapeutic target.
Recent studies indicate both clinical and mechanistic links
between atherosclerotic heart disease and intestinal microbial
metabolism of certain dietary nutrients producing trimethyl-
amine N-oxide (TMAO). Here we test the hypothesis that gut
microbial transplantation can transmit choline diet-induced
TMAO production and atherosclerosis susceptibility. First, a
strong association was noted between atherosclerotic plaque
and plasma TMAO levels in a mouse diversity panel (n  22
strains, r  0.38; p  0.0001). An atherosclerosis-prone and high
TMAO-producing strain, C57BL/6J, and an atherosclerosis-re-
sistant and low TMAO-producing strain, NZW/LacJ, were
selected as donors for cecal microbial transplantation into apo-
lipoprotein e null mice in which resident intestinal microbes
were first suppressed with antibiotics. Trimethylamine (TMA)
and TMAO levels were initially higher in recipients on choline
diet that received cecal microbes from C57BL/6J inbred mice;
however, durability of choline diet-dependent differences in
TMA/TMAO levels was not maintained to the end of the study.
Mice receiving C57BL/6J cecal microbes demonstrated choline
diet-dependent enhancement in atherosclerotic plaque burden
as compared with recipients of NZW/LacJ microbes. Microbial
DNA analyses in feces and cecum revealed transplantation of
donor microbial community features into recipients with differ-
ences in taxa proportions between donor strains that were trans-
missible to recipients and that tended to show coincident pro-
portions with TMAO levels. Proportions of specific taxa were
also identified that correlated with plasma TMAO levels in
donors and recipients and with atherosclerotic lesion area in
recipients. Atherosclerosis susceptibility may be transmitted via
transplantation of gut microbiota. Gut microbes may thus rep-
resent a novel therapeutic target for modulating atherosclerosis
susceptibility.
It has long been known that trillions of bacteria colonize our
intestines, but only recently has the intestinal microbial commu-
nity been appreciated as a biologically active participant in human
health and disease (1–4). Our laboratory has elucidated a link
between intestinal microbiota, dietary trimethylamine-contain-
ing nutrients (e.g. choline, phosphatidylcholine, and carnitine),
and cardiovascular disease (5–7). Using an unbiased metabolomic
approach, we initially discovered that phosphatidylcholine, the
major dietary source of choline, and the gut microbe-depen-
dent metabolite, trimethylamine N-oxide (TMAO),4 are both
mechanistically linked to atherosclerosis development (5, 6, 8)
and that plasma levels in subjects are associated with prevalent
and incident cardiovascular disease risks (5, 7, 9, 10). Oral die-
tary supplementation with the trimethylamine (TMA)-con-
taining precursors, choline or carnitine, and dietary TMAO
directly, were each shown to enhance aortic root atheroscle-
rotic plaque in the atherosclerosis-prone C57BL/6J apolipopro-
tein e null (Apoe/) mouse model. An obligatory role for gut
microbes in TMAO formation in both mice (5, 6) and humans
(7) was shown, and the involvement of gut microbes in athero-
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sclerosis susceptibility was suggested by demonstrating that
both dietary choline-induced and carnitine-induced enhance-
ment in atherosclerosis in mice is prevented by suppression of
gut microbes (and TMAO formation) with poorly absorbed
broad spectrum oral antibiotics (5, 6).
Following Koch’s postulates (11–13), if the disease-causing
entity is a microbe, differences in disease susceptibility should
follow transplantation of the microbe into a new host. Here we
investigate whether atherosclerosis susceptibility can be trans-
mitted by cecal microbial transplantation. We hypothesized
that cecal contents might serve as a relatively stable and trans-
plantable microbial community to permit simultaneous testing
of two distinct hypotheses: (i) that choline diet-dependent
capacity for TMA and TMAO generation is a transmissible
trait; and (ii) that atherosclerosis susceptibility may be trans-
mitted to a recipient host by microbial transplantation. Cecal
contents from distinct inbred donor strains with differing ath-
erosclerosis potential and TMAO production capacity were
identified and then introduced via gastric gavage into recipient
mice in which endogenous gut microbes were initially sup-
pressed through use of an oral poorly absorbed antibiotic mix-
ture. We now show that recipients demonstrated altered TMA
and TMAO production capacity and atherosclerosis disease
susceptibility, indicating that atherosclerosis susceptibility is a
transmissible trait.
EXPERIMENTAL PROCEDURES
General Procedures and Reagents—All procedures were
approved by Institutional Animal Care and Use Committees
within both the Cleveland Clinic and the University of Califor-
nia in Los Angeles. Glucose, cholesterol, and triglyceride levels
were quantified on a Roche Diagnostics Applied Science Cobas
4000 analyzer series instrument as described (6). Internal
standards for mass spectrometry studies (d9-TMA and
d9-TMAO) were obtained from Cambridge Isotopes Laborato-
ries, Inc., Andover, MA. HDL cholesterol was determined with
colorimetric assay of the HDL cholesterol-containing fraction
isolated following buoyant density ultracentrifugation as
described (6). Flavin-dependent monooxygenase activity was
determined from an 8-h reaction of liver homogenate (800
mg/liter of protein final, generated from livers homogenized
with a TissueLyser II; Qiagen, Valencia, CA) with 100 M
d9-TMA and 100 M reduced NADPH in 10 mM HEPES buffer,
pH 7.4, as described previously (8). Stable isotope dilution liq-
uid chromatography with on-line tandem mass spectrometry
(LC/MS/MS) was used to quantify TMA and TMAO levels in
plasma, as well as total choline content in food following base
hydrolysis, as described previously (5, 14) using an AB SCIEX
API 5000 triple quadrupole mass spectrometer.
Mouse Diversity Panel Studies—TMAO was measured in
plasma recovered from mice from a mouse diversity panel.
Briefly, 22 distinct inbred strains (see Table 1) were crossed
with C57BL/6J mice homozygous for the human apolipopro-
tein B transgene. F1 progeny at 9 weeks of age were placed on a
Paigen diet (Teklad diet TD.88051) until time of sacrifice at 25
weeks of age when aortic root atherosclerotic plaque was quan-
tified and plasma was recovered, as described previously (15).
Mouse Cecal Transplant Studies—Female C57BL/6J Apoe/
mice at the time of weaning (4 weeks of age) were placed on a
mixture of broad spectrum, poorly absorbed antibiotics (van-
comycin, neomycin sulfate, metronidazole, and ampicillin, as
described previously (5)) for 3 weeks to suppress intestinal
microbes. Mice were then taken off the antibiotics and serially
orally gavaged with donor cecal contents from strains identified
as atherosclerosis-prone (C57BL/6J) versus atherosclerosis-re-
sistant (NZW/LacJ), as outlined below and in Fig. 2. Mice were
placed on either a chemically defined diet comparable in com-
position with normal “chow” (Teklad diet 2918) or the same
diet supplemented with additional choline (1.0%, w/w; Teklad
diet TD.09041). All drinking water (/ antibiotics) and all
diets used were sterilized. Control studies examined the choline
content in diets following sterilization procedures and showed
the total choline content of the chow and choline diets to be
0.07  0.01 and 1.06  0.01%, respectively. Blood was collected
via saphenous vein to measure plasma TMAO throughout the
experiment in the four Apoe/ female recipient experimental
arms: 1) those receiving donor C57BL/6J cecal microbes and
placed on the choline diet; 2) those receiving donor C57BL/6J
microbes and placed on the chow diet; 3) those receiving donor
NZW/LacJ cecal microbes and placed on the choline diet; and
4) those receiving donor cecal NZW/LacJ microbes and placed
on the chow diet.
Cecal microbial contents from donor mice (female, 14 weeks
old on average, C57BL/6J or NZW/LacJ) were harvested from
euthanized mice by rapidly removing the cecum and then man-
ually extruding the contents into a vial containing sterile argon-
sparged PBS (1.5 ml/0.2 ml of cecal volume). Following succes-
sive passages through an 18- and then a 20-gauge needle, the
suspended cecal contents from one donor mouse were intro-
duced via gastric gavage using a 22-gauge feeding needle into
five recipient mice (0.2 ml each). Stable isotope dilution
LC/MS/MS analysis of TMAO and TMA was measured in a
sampling of cecal slurries across the duration of the study. The
TMAO content in cecal donor slurries was below the limit of
detection in all samples (30 fmol on column, or 0.01 M
within the slurry). The median TMA content in donor cecal
slurries was 3 nmol (amount within inoculum) for C57BL/6J,
and 2.5 nmol for NZW/LacJ mice. Thus, the amounts of TMA
and TMAO present in the inocula were negligible (2% total
body pool of TMA  TMAO). Total time between euthanizing
of a donor and installation of microbial contents into recipients
via gastric gavage was kept as short as possible (15 min). Recip-
ient mice received cecal microbial suspensions via gastric
gavage initially daily for 5 successive days starting on the day
antibiotics were removed from drinking water and separation
into the dietary arms. Cecal transplantation (with freshly har-
vested cecal contents from new donor mice for each gavage)
were then continued on a schedule of every other day for
another week, and then weekly thereafter until time of animal
sacrifice for atherosclerosis plaque quantification at 20 weeks of
age (see Fig. 2). Feces were collected from individual recipient
mice at least 48 h after oral gavage (collection day was the day
before the new gavage for the subsequent week). Separate con-
trol studies showed that waiting 48 h after gavage allowed
microbial DNA isolated from feces collected under this sched-
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ule to have minimal detectable contamination from DNA in the
gavage and to thus arise predominantly from the endogenous
microbial community.
Donor mice were maintained on the chemically defined diet
with lower choline content (chow) and housed in separate
areas. Within the colony of each donor strain (C57BL/6J versus
NZW/LacJ), fecal pellets and mice were constantly transferred
among cages to help maintain a unified microbial composition
among all mice within a given donor inbred strain. Similarly,
mice within the recipient C57BL/6J Apoe/ colony prior to
enrollment in studies were maintained on chow diet, continu-
ously cohoused using harem breeding, and with similar contin-
ual transfer of fecal pellets among cages within the colony. At
time of weaning, cohoused siblings were split into separate
cages, housed in a different room, and still maintained on chow
diet during the 3-week antibiotic treatment period. On the
morning of the first cecal microbial transplant, antibiotic treat-
ment was stopped, and mice were divided into the indicated
recipient groups based on diet and donor. All mice were sepa-
rately housed, and mice within a given group were maintained
on separate racks. Husbandry personnel changed protective
outerwear and used clean technique between handling the dis-
tinct groups of mice. Husbandry chores in the different groups
of mice were performed on separate days to further decrease
chances of microbial cross dissemination.
Mouse Atherosclerosis Studies—Recipient mice were eutha-
nized and evaluated for aortic root atherosclerosis area quanti-
fication at 20 weeks ( 1 day) of age. Hearts were fixed and
stored in formalin or frozen in OCT. After sectioning, slides
were stained with Oil-Red-O and hematoxylin or with immu-
nohistochemical staining as outlined below. Aortic root lesion
area was quantified by computer-assisted planimetry taking the
mean value from six sections, as described previously (5, 6).
Immunohistochemical staining for Iba1 (ionized calcium-bind-
ing adapter molecule 1), a specific marker for macrophages (16,
17), was carried out in parallel on sections adjacent to those
used for Oil-Red-O analysis. Before immunohistochemical
staining, high temperature antigen retrieval in citrate retrieval
buffer, pH 6.0, utilizing the Decloaking Chamber (Biocare Med-
ical, Concord, CA) and the 15-min, 95 °C program, was per-
formed. All materials used for Iba1 staining were from Vector
Laboratories (Burlingame, CA) unless otherwise indicated. Sec-
tions were blocked in 3% normal goat serum in PBS, as well as
avidin D and biotin blocking solution. Slides were incubated at
room temperature for 30 min with rabbit anti-Iba1 primary
antibody (Wako Chemicals USA, Inc., Richmond, VA) diluted
1:500 with PBS supplemented with 1.5% (v/v) normal goat
serum. Biotinylated anti-rabbit secondary antibody (1:200
dilution) was applied for 30 min at room temperature, fol-
lowed by Vector ABC alkaline phosphatase reagent and then
Vector Red substrate for fluorescence visualization. Sections
were mounted in VECTASHIELD mounting medium for fluo-
rescence imaging with DAPI staining for nuclei. Images were
collected using a Leica SCN 400 slide scanner (Leica Microsys-
tems Inc., Buffalo Grove, IL), and quantification of Iba1-stained
area was carried out using ImagePro9 software (Microsoft, Red-
mond, WA). Results represent mean  S.E. of computer-as-
sisted planimetry from the indicated numbers of animals (taken
at the level of the aortic ring annulus). Images shown are rep-
resentative pictures from each group (red color channels in gray
scale).
Microbiota Studies and Statistical Analyses—Microbial DNA
was isolated with PowerSoil DNA isolation kit (MO BIO Labora-
tories, Inc., Carlsbad, CA) from samples stored at 80 °C.
Amplification and sequencing of V4 hypervariable region of the
16 S rRNA gene were performed using the validated, region-
specific bacterial primers 515F and 806R according to a previ-
ously described method (18, 19). High throughput sequencing
analysis of bacterial rRNA genes was performed using the Illu-
mina MiSeq platform (Illumina, Inc., San Diego, CA) at the
GenoSeq Core facility, University of California, Los Angeles.
De-multiplexing 16 S rRNA gene sequences, quality control,
and operational taxonomic unit binning were performed using
open source pipeline Quantitative Insights Into Microbial Ecol-
ogy (QIIME) version 1.7.0 (20) and established guidelines (21).
Quality-filtered reads were de-multiplexed, yielding 881,836
sequences total with an average length of 153 bases per read,
and an average coverage of 15,204 sequences per sample.
Sequences were binned into operational taxonomic units based
on 97% identity using UCLUST (22) against the Greengenes
reference database (23). The taxonomic composition was
assigned to the representative sequence of each operational tax-
onomic unit using the Greengenes database. The sequences of
each sample were rarefied to a depth of 10,500 sequences per
sample to reduce the effect of sequencing depth, and then used
for downstream analysis. The beta diversity of samples was mea-
sured using the weighted UniFrac metric (24), and the dimen-
sionality reduction technique of principal coordinates analysis
was used to visualize the community differences between
C57BL/6J and NZW/LacJ strains. Additional analyses were car-
ried out on cecal samples to examine success of transplant in
recipients at the study end point. The beta diversity distance
matrix was calculated for the cecal samples of donors and recip-
ients and visualized using unweighted pair group method with
arithmetic mean, which forces the samples into an ultrametric
tree. The resulting tree file was visualized by the TopiaryEx-
plorer program (25).
In additional analyses, the LDA effect size (LEfSe) algorithm
(26, 27) was used to identify taxa that account for the greatest
differences between donor strain microbiota in cecal and fecal
sequencing data. The algorithm, which was designed to aid in
biomarker discovery from large datasets, performs Kruskal-
Wallis rank-sum test between main classes, Wilcoxon on sub-
classes, followed by linear discriminate analysis (LDA) to assign
a signed score. C57BL/6J taxa are indicated with positive LDA
score (red), and taxa enriched in NZW/LacJ donors have a neg-
ative LDA score (green). Only taxa meeting an LDA significance
threshold 2 are shown. Ten characteristic taxa were identified
using LEfSe analyses that were characteristic of donor origin
whether analyzed in samples from cecum or feces. Then, the
proportions of these taxa were examined in feces of recipient
mouse groups longitudinally over time as a secondary exami-
nation of success of gut microbial transplantation. These 10
taxa also served as the focus of examination for evaluating the
relationships between “donor characteristic” taxa proportions
in recipient mice and either plasma TMAO levels or aortic root
Atherosclerosis Susceptibility Is Transmissible
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atherosclerosis lesion area. p values reported are false discovery
rate adjusted. Adjusted post tests were used to compare two
groups at any time. One-way analysis of variance was carried
out to determine differences among the four recipient groups.
Spearman’s rank-order correlations were calculated to deter-
mine associations between taxa proportions and TMAO or ath-
erosclerotic plaque levels. All values are expressed as mean 
S.E.
RESULTS
Mouse Diversity Panel Reveals Inbred Strains with Divergent
Susceptibility to Atherosclerosis and Plasma TMAO Levels—To
identify mice for use as potential donors for cecal microbial
transplantation studies, we utilized a previously studied (8, 15)
panel of inbred strains of mice (Table 1) crossed with C57BL/6J
mice carrying the human apolipoprotein b transgene to accel-
erate atherosclerosis. Plasma TMAO levels were analyzed in
Apob hemizygous female F1 progeny following 16 weeks of ath-
erosclerotic diet and recovered at time of animal sacrifice for
aorta harvest (n  4 –13 mice per inbred strain, with most
strains n  8). Examination of the relationship between aortic
root atherosclerotic plaque burden and plasma TMAO levels in
mice within the majority of each inbred strain (not shown), and
across the different inbred strains examined, showed a remark-
ably strong positive association (r  0.38, p  0.0001; Fig. 1A;
Table 1). From this panel, we tentatively selected two inbred
strains to serve as potential cecal microbial community donors:
(i) C57BL/6J mice as an atherosclerosis-prone donor strain, with
concurrent high TMAO and high lesion area; and (ii) NZW/LacJ
mice as an atherosclerosis-resistant donor strain, with concurrent
low TMAO and low lesion area (Fig. 1A; Table 1).
The atherosclerosis studies in the above mouse diversity
panel examined Apob hemizygous mice on the Paigen diet, an
atherogenic diet with moderate and somewhat variable choline
content (because it is not one of the defined components in the
diet). Before proceeding with cecal microbial transplant stud-
ies, we therefore sought to confirm that the selected inbred
strains recapitulated a wide divergence in plasma TMAO levels
on a less atherogenic but chemically defined high choline con-
tent diet. Female mice (8 weeks of age) from each inbred donor
strain were placed on a chemically defined diet supple-
mented with choline chloride (total choline content 1.06%),
and plasma levels of TMAO were monitored. Significant (p 
0.05) increases in TMAO levels were observed in both strains of
mice. Importantly, whereas only modest increases in plasma
TMAO levels were observed in the NZW/LacJ mice, a far
greater rise was observed within the C57BL/6J mice (Fig. 1B).
Parallel LC/MS/MS analyses similarly showed significantly
higher plasma TMA levels within the C57BL/6J versus NZW/
LacJ donors (12.7  1.9 M versus 1.1  0.4 M, respectively, at
14 day time point; p  0.006).
Cecal Microbial Transplant Studies Show Transmissibility of
Donor Strain Diet-dependent Plasma TMA and TMAO Levels—
The overall schedule of the cecal microbial transplantation stud-
ies is shown in Fig. 2 (top panel). Recipient Apoe/ female
TABLE 1
Relationship between plasma TMAO and aortic lesion area in mouse
diversity panel
Plasma TMAO and aortic root atherosclerosis plaque extent quantified in female F1
progeny of the mouse diversity panel as described under “Experimental Proce-
dures.” Data shown represent mean results and S.E. within the female F1 heterozy-
gotes examined (cross between the indicated inbred background strain and
homozygote C57BL/6-tg(Apob) mice. Strains appear in rank order of lesion area
from least to greatest. Symbols shown correspond to the mouse strains plotted in
Fig. 1.
FIGURE 1. Aortic lesion area and plasma TMAO levels are positively asso-
ciated across multiple inbred strains of mice. A, atherosclerotic plaque and
plasma TMAO levels were determined in female F1 progeny from the cross
between C57BL/6 mice homozygous for the human Apob transgene and 22
distinct inbred strains of mice (Table 1) as described under “Experimental
Procedures.” Each data point represents the mean  S.E. of lesion area and
terminal plasma TMAO level within each strain, with Spearman correlation
across all strains shown. Inbred strains with markedly divergent atherosclero-
sis susceptibility and TMAO levels selected to serve as cecal microbe donors
included the atherosclerosis-prone (large lesion and high plasma TMAO)
C57BL/6J (red) and atherosclerosis-resistant (small lesion and low plasma
TMAO) NZW/LacJ (blue) strains. The key for symbols, along with mean  S.E.
values for atherosclerosis area and TMAO levels in each strain, are found in
Table 1. B, confirmation that selected donor strains, C57BL/6J and NZW/LacJ,
demonstrate markedly different TMAO plasma levels on a choline-supple-
mented diet. Selected donor strains were placed on the choline-supple-
mented (1.06%, w/w) diet, and plasma TMAO levels were quantified at the
indicated times (n  4/group at each time point). *, p  0.05 and **, p  0.01
for comparison with baseline (prior to choline diet) plasma TMAO level in
each inbred strain.
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mice at the time of weaning were placed on a mixture of broad
spectrum, poorly absorbed antibiotics for 3 weeks to suppress
intestinal microbes. The day antibiotics were stopped, mice
were placed on chow- versus choline-supplemented diets, and
recolonization efforts were begun with serial gastric gavage
with donor cecal microbe suspensions from atherosclerosis-
prone versus atherosclerosis-resistant inbred strains (C57BL/6J
versus NZW/LacJ, respectively), as described under “Experi-
mental Procedures.” Examination of plasma TMA and TMAO
levels over time revealed that both recipient groups on the cho-
line-supplemented diet showed higher TMA and TMAO levels.
In addition, comparison between the recipient groups on the
choline diet showed that initially following gut microbial trans-
plantation (8 weeks of age), mice receiving cecal microbes from
the C57BL/6J donors had higher TMA and TMAO levels than
those receiving cecal microbes from the NZW/LacJ mice (e.g.
for TMAO, 123.0  15.3 M versus 93.2  8.6 M; p  0.05). At
12 weeks of age on the high choline diet, recipients gavaged
with C57BL/6J cecal microbes still showed significantly
higher TMA levels (p  0.01) and a tendency toward
increased plasma TMAO levels as compared with the NZW/
LacJ group (for TMAO, 145.4  17.8 M versus 113.4  11.7
M; p  0.1). However at 16 and 20 weeks of age, both TMAO
and TMA levels in the two high choline diet groups of mice
were overlapping (Fig. 2).
Atherosclerosis Susceptibility Is Transmitted via Gut Micro-
bial Transplantation—At the study end point (20 weeks of age),
aortic root atherosclerotic plaque area was quantified (Fig. 3).
Characteristic images from Oil-Red-O staining of each group of
mice are illustrated in Fig. 3A. Remarkably, recipients of cecal
microbial transplantation from the C57BL/6J donors, but not
the NZW/LacJ donors, showed dietary choline-dependent
enhancement (1.5-fold, p  0.02) in atherosclerosis (Fig. 3C).
No differences in atherosclerotic plaque area were noted
between recipient groups on the low choline (chow) diet. Exam-
ination of the association between aortic lesion area and plasma
TMAO within the mice receiving cecal microbes from athero-
sclerosis-prone donors, C57BL/6J, showed a positive correla-
tion (r  0.51, p  0.006) (Fig. 3D).
In parallel studies, adjacent aortic root sections were used for
macrophage quantification by immunohistochemical staining
with anti-Iba1, a macrophage specific cell surface marker (16,
17). Similar results were observed with recipient mice that were
gavaged with C57BL/6J cecal microbes and maintained on the
high choline diet, showing significantly greater stained area for
macrophages within the lesion than similarly treated mice
except for receipt of NZW/LacJ donor microbiota (Fig. 3, B and
E). Characterization of plasma lipids (total cholesterol, triglyc-
erides, and HDL cholesterol) from the two donor strains at the
time of cecal content harvest showed higher HDL cholesterol
and total cholesterol in the atherosclerosis-resistant NZW/LacJ
inbred strain (Table 2). However, parallel examination among
each of the recipient mouse groups from plasma collected at 8
weeks (not shown) and study termination (20 weeks) showed
no significant differences (Table 3), indicating no evidence for
dyslipidemic changes to account for the observed differences
in atherosclerosis. Examination of plasma glucose and weights
between the different groups of recipient mice similarly revealed
no significant differences (Table 3). Liver flavin-dependent
monooxygenase activity was determined in recipient mice at
time of organ harvest in both donor (Table 2) and recipient
mice (Fig. 4). No significant differences were observed overall
among donors and recipients, or between donor groups of mice
(Table 2). Among the recipients, those receiving NZW/LacJ
cecal microbes and choline diet showed reduced total hepatic
FMO activity (Fig. 4).
FIGURE 2. Cecal transplant experiment design, and plasma TMA and
TMAO levels following transplantation of donor cecal microbiota. Top,
cecal microbial transplantation study design. The timeline shows that recipi-
ent mice upon weaning were administered a mixture of broad spectrum anti-
biotics for 3 weeks. At 7 weeks of age, administration of antibiotics was ter-
minated, and cecal microbial transplantation began with a gavage of cecal
slurry freshly harvested from euthanized donor mice daily the first week,
every other day the second week, and then weekly until the 20 weeks of age
study end point. Vertical arrows indicate where timing of cecal microbial
gavages changed. Middle and bottom, plasma TMAO (middle) and TMA (bot-
tom) levels in the four recipient groups were monitored to track transmissi-
bility of choline diet-dependent donor TMA/TMAO levels. Open symbols at 4
weeks of age represent plasma TMA and TMAO levels in recipients at time of
weaning, prior to antibiotic administration. The dotted line at 7 weeks of age
represents the end of administration of antibiotics and the beginning of both
serial cecal microbial gavages, as well as the indicated diets. *, p  0.05, **, p 
0.01 for comparison between similar time point recipients on the high choline
diet of cecal microbe suspensions from C57BL/6J versus NZW/LacJ donors.
Data points represent mean  S.E.
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Characterization of Microbial Communities in Donor and
Recipient Mice—We next sought to examine intestinal micro-
bial composition within the donor strains (C57BL/6J versus
NZW/LacJ) and to see whether features of the community
structure were transplanted to the recipients. Over the course
of the studies, the average age of donors from each inbred strain
used was 14.8  1.4 weeks for C57BL/6J and 14.0  1.2 for
NZW/LacJ. Initial analyses were performed on microbial DNA
encoding 16 S rRNA recovered from cecal contents used in gas-
tric gavages. Principal coordinate analyses of donor cecal
microbial compositions showed distinct microbial commu-
nities for the inbred C57BL/6J and NZW/LacJ strains (Fig.
5A). When beta diversity measures of the cecal samples of
the donors and the four recipient groups were examined
within a hierarchal tree, microbial compositions of the recip-
ient groups clearly clustered with the compositions of their
respective donor (Fig. 5B).
We next further examined the fecal microbial compositions
of the donor mice, which could be compared with the fecal
microbial compositions of recipients collected over the course
of the transplantation studies. To visualize overall differences,
the percent abundances of genera within each of the two donor
strains (n  15 C57BL/6J, and n  16 NZW/LacJ) are plotted
with taxa color-coded for the strains containing greater abun-
dance (reds for C57BL/6J and blues for NZW/LacJ) (Fig. 6).
Visual inspection identifies clear differences, but we also sought
to perform quantitative analyses to more robustly identify
microbial taxa to help discriminate between C57BL/6J versus
NZW/LacJ donors when examined in both fecal and cecal
FIGURE 3. Demonstration of choline diet-dependent transmissibility of atherosclerosis. At 20 weeks of age, the indicated numbers of recipient groups of
Apoe/ female mice were sacrificed, and aortic atherosclerotic plaque was quantified. Groups are defined by the indicated diet arm (chow versus choline) and donor
source for cecal microbial suspensions given by gastric gavage (atherosclerosis-prone C57BL/6J versus atherosclerosis-resistant NZW/LacJ). A, representative Oil-
Red-O staining images from each group. B, representative images following immunohistochemical staining with antibodies to the macrophage marker Iba1 from each
group. C, aortic root lesion area quantified using Oil-Red-O staining, as described under “Experimental Procedures,” from the indicated numbers of mice. ANOVA,
analysis of variance. D, relationship between aortic root lesion area (on y axis, in units of m2 	 100,000) and plasma TMAO levels among recipients of cecal
microbes from atherosclerosis-prone C57BL/6J donors, and Spearman rank correlation (r  0.51, p  0.006). E, aortic root lesion area quantified using
Iba1 staining, as described under “Experimental Procedures,” from the indicated numbers of mice. Data points represent mean  S.E.
TABLE 2
Characterization of traditional risk factors and liver FMO activity in
donor strains of mice
Donor plasma and livers were collected at the time of cecal content harvest. Total
cholesterol, triglycerides, glucose, and HDL cholesterol were quantified as outlined
under “Experimental Procedures.” Liver flavin-dependent monooxygenase activity,
expressed in nmol of d9-TMAO formed per mg of protein/hour, was determined as






Triglyceride 71  5 112  5 0.0001
Total Cholesterol 78  4 138  10 0.0001
HDL 41  7 71  7 0.003
Glucose 193  17 169  16 0.3
Liver FMO activity (nmol/mg/h) 0.036  0.010 0.049  0.010 0.4
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microbial compositions. Fecal samples could be monitored in
recipients longitudinally over the course of the transplantation
studies, and cecal samples were available at the end of the study.
For these analyses, we used the recently described LEfSe algo-
rithm (26) for comparative microbial composition analyses,
permitting the characterization of microbial taxa whose pro-
portions are characteristic of differences between donor micro-
bial communities. Initial global comparisons between cecal
microbial communities from the C57BL/6J versus NZW/LacJ
donors revealed 20 genus level taxa characteristic of donor
inbred strain (Fig. 7A). Parallel analyses of fecal microbial com-
munities revealed 13 donor strain characteristic taxa, 10 of which
overlapped with the characteristic taxa identified in cecal micro-
biota analyses (Fig. 7B). Overlapping taxa characteristic of donor
strain (higher proportions) in both cecum and feces are labeled in
red for C57BL/6J or in blue for NZW/LacJ donor mice.
We then examined the distribution of percent abundances of
the 10 overlapping donor characteristic taxa in the recipient
groups at different time points. The bar graphs in Fig. 8A show
the percent abundances accounted for by the 10 characteristic
taxa in the context of genera (including the genus level taxa that
did not qualify for further analysis) for donors and recipients.
The 10 donor characteristic taxa represent 6.2% of the micro-
bial community detected in C57BL/6J donor mice feces, and
13.8 –15.5 and 9.8 –13.3% (range observed in 8 –20-week sam-
ples) in the feces of recipient mice on chow and choline diets
that were gavaged with C57BL/6J cecal microbes (Fig. 8A).
Graphical representation of the proportions of these 10 taxa in
TABLE 3
Characterization of traditional risk factors among recipient groups of mice in cecal microbial transplant studies
Recipient plasma at study termination (20 weeks) was collected. Total cholesterol, triglycerides, glucose, and HDL cholesterol were quantified as outlined under “Experi-
mental Procedures.” Recipient weights shown were collected at the end of the study. Data shown are mean  S.E. for each of the groups.
Plasma chemistry
(mg dl1)
C57BL/6J Apoe/ recipient mice p value










(n  16) C57BL/6J NZW/LacJ Chow Choline
Triglyceride 81  7 72  6 71  3 69  10 0.2 0.8 0.2 0.6
Total cholesterol 299  16 277  9 299  14 294  11 0.2 0.8 0.8 0.5
HDL 28  5 26  3 24  2 28  3 0.4 0.4 0.1 0.9
Glucose 236  12 215  18 204  13 195  11 0.07 0.4 0.1 0.8
Body weight(g) 23.8  0.4 23.8  0.4 23.2  0.5 22.3  0.3 0.4 0.1 0.2 0.06
FIGURE 4. Hepatic flavin monooxygenase activity among recipient mice.
Total FMO activity in liver homogenates was determined as described under
“Experimental Procedures” using liver recovered from the indicated recipient
Apoe/ mice included in the aortic atherosclerotic plaque study. As in Fig. 3,
groups are defined by the indicated diet arm (chow versus choline) and donor
source for cecal microbial suspensions given by gastric gavage (atheroscle-
rosis-prone C57BL/6J versus atherosclerosis-resistant NZW/LacJ).
FIGURE 5. Demonstration of distinct cecal microbial compositions between
donor strains and relatedness between donors and their respective recipi-
ent groups regardless of dietary arm. A, unweighted UniFrac distances plotted
in principal coordinates analysis space comparing cecum microbial communities
between two donor strains. Each data point represents a sample from a distinct
mouse projected onto the first two principal coordinates (percentage of variation
explained by each principal coordinates (PCo) is shown in parentheses). Circles
represent C57BL/6J, and squares represent NZW/LacJ. B, unweighted pair group
method with arithmetic mean clustering on the cecal samples from the two
donor groups and all four recipient groups collected at 20 weeks of age. Beta
diversity distance matrix distances are displayed into a hierarchical tree in which
branches, and lengths illustrate how closely the groups are related to one
another. Recipients of cecal microbes from C57BL/6J donors, regardless of diet,
are more closely related to C57BL/6J donors, and conversely, recipients of cecal
microbes from NZW/LacJ donors, regardless of diet, are more closely related to
NZW/LacJ donors.
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pie charts illustrates that Allobaculum is a taxa more abundant
among the 10 taxa examined within the C57BL/6J but not
NZW/LacJ donors (red) (Fig. 8B), and whose proportions in
recipients of C57BL/6J cecal microbes remain prominent at
both early (8-week; Fig. 8B) and late (20-week; Fig. 9) time
points, regardless of dietary arm. For NZW/LacJ donor mice,
these same 10 taxa represent 18.4% of fecal microbial 16 S
rRNA encoding DNA, and 20.7–22.3 and 22.0 –32.4% (range
observed in 8 –20-week samples) of fecal microbes within recip-
ients that were gavaged with NZW/LacJ cecal microbes (Fig. 8A,
right side). Bacteroides (blue) is an abundant taxa characteristic of
the NZW/LacJ donors, and the proportions of this taxa were more
prominent in the recipients receiving the NZW/LacJ cecal
microbes, regardless of dietary arm and time point examined (Figs.
8B and 9A). The overall differences between C57BL/6J and NZW/
LacJ recipient groups confirm that the cecal microbial transplant
protocol used resulted in substantial reorganization of the com-
munity structures in the host. Examination of the overall propor-
tions of fecal bacterial taxa characteristic of the donor inbred strain
revealed that, like the functional studies examining plasma TMA
and TMAO levels, the characteristic differences over time after
cecal transplantation became less pronounced (Fig. 9A). Similar
analyses were carried out on the Apoe/ weanlings prior to
microbiota suppression with antibiotic administration (Fig.
9B). Substantial differences in community structures
between the recipients prior to antibiotics, versus study end
point, are noted in all recipient groups regardless of diet or
donor cecal microbes gavage.
Proportions of Select Transplanted Microbial Taxa Are Cor-
related within Recipient Plasma TMAO and Atherosclerosis—
We next examined the relationship between proportions of
fecal bacterial taxa and plasma TMAO levels in both donors
and 8-week-old recipients, the time point in recipients when
the greatest diet- and donor-dependent differences in plasma
FIGURE 6. Fecal microbial compositions of donor strains. Percent abun-
dances of genus level taxa displayed in a stacked bar graph show differences
between inbred donor strains (data for chow diet shown). Taxa in higher
abundance in C57BL/6J donors are colored in reds, and those higher in NZW/
LacJ donors are displayed in blues. Results shown represent averages among
C57BL/6J (n  15) and NZW/LacJ (n  16) donors.
FIGURE 7. Defining donor characteristic taxa in cecal and fecal microbiota. A and B, microbial DNA encoding 16 S rRNA was analyzed from C57BL/6J and
NZW/LacJ cecum (A) and feces (B) (n  15 for both donor groups). Shown is a histogram displaying LDA scores calculated with the LEfSe algorithm identifying
taxa most characteristic (increased abundance) of donor strain type, as described under “Experimental Procedures.” Taxa enriched in C57BL/6J are indicated
with a positive LDA score (red), and taxa enriched in NZW/LacJ donors have a negative LDA score (blue). Only taxa meeting an LDA significance threshold 2
are shown. Donor characteristic taxa common to both cecal and fecal microbiota (10 overlapping taxa were identified) are indicated with color label: red for
C57BL/6J characteristic donor; blue for NZW/LacJ characteristic donor.
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TMAO were observed. Proportions of Prevotella were strongly
associated with TMAO levels (r  0.44, p  0.0003; Fig. 10A), a
genus we recently reported was associated with TMAO levels in
cecal microbes from carnitine-supplemented mice (6). Because
of the observed association between the relative abundance of
Prevotella and plasma TMAO, cecal microbial donor, and die-
tary groups at this early time point, we examined the abundance
of Prevotella at later time points to see whether differences
among the groups were maintained (Fig. 10B). By 16 weeks, the
effect of choline diet on relative abundances of Prevotella were
non-significant (i.e. recipients of C57Bl/6J cecal microbes on
chow versus choline diets no longer showed significant differ-
ences), similar to the changes in levels of TMAO observed (Fig.
2). Also, by the end of the study, the relative abundances of
Prevotella in all four groups were overlapping. We also exam-
ined whether Prevotella proportions were associated with ath-
erosclerosis plaque quantification in the mice. Across all four
groups of mice, no significant correlation was observed (r 
0.06, p  0.6). However, a strong positive correlation was noted
with atherosclerosis extent among the two recipient groups on
the choline-supplemented diet (r  0.37, p  0.02; Fig. 10C),
and a significant inverse association was observed among the
two recipient mice groups receiving chow (low choline) diet
(r  0.33, p  0.03).
Further analyses revealed several additional microbial taxa
whose proportions were characteristic of the donor microbial
community and TMAO levels. In general, C57BL/6J donor
strain characteristic taxa tended to be positively correlated with
TMAO, and NZW/LacJ characteristic taxa were negatively cor-
related with TMAO values. For example, when the relationship
FIGURE 8. Donor microbial community features transfer to recipients. The 10 overlapping donor characteristic taxa from LEfSe analysis of donor cecal and fecal
samples (Fig. 7) were selected for further investigation in recipient mice. A, stacked bar graphs showing the percent abundance accounted for by the 10 selected taxa
within DNA encoding the 16 S rRNA recovered from feces from the indicated donors and recipients. The key at the right lists the taxa with assigned color. Red, orange,
and yellow colors indicate taxa higher in abundance in C57BL/6J donors, and blue, purple, and green colors indicate taxa higher in abundance in NZW/LacJ donors. B, pie
charts of average abundance of these 10 taxa for the two donor groups (top) and the four recipient groups in feces recovered at 8 weeks of age.
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with TMAO levels was interrogated in recipients (8 week,
feces), restricting examination to the 10 donor characteristic
taxa identified by LEfSe analysis of both cecal and fecal donor
microbial communities (Fig. 7), the proportions of 5 of the 10
taxa (50%) showed a significant (p  0.05) correlation with
plasma TMAO levels. Similarly, proportions of the 10 donor
characteristic taxa within recipient fecal (8-week) microbes
showed that half of the taxa significantly (p  0.05) correlated
with atherosclerosis extent.
An example of a “C57BL/6J donor characteristic” taxa that
was positively correlated with plasma TMAO from 8-week-old
recipients was the Erysipelotrichaceae family (r  0.30, p 
0.03; Fig. 11A). The proportions of Erysipelotrichaceae within
recipient feces were also significantly positively correlated with
aortic root atherosclerotic plaque development among recipi-
ents of atherosclerosis-prone cecal microbes (C57BL/6J) (r 
0.40, p  0.01; Fig. 11A), and a borderline inverse association
was observed among NZW/LacJ recipient groups (r  0.26,
p  0.05). No significant association was noted with atheroscle-
rosis among all four groups (r  0.05, p  0.6). Similarly, the
proportions of the taxa (order) RF39 in feces from 8-week-old
recipient mice, a “C57BL/6J characteristic” taxa identified in
fecal and cecal microbiota analyses (Fig. 7), demonstrated pos-
itive association with atherosclerosis extent among all groups of
mice (r  0.21, p  0.04; Fig. 11B), and a strongly positive
association with plasma TMAO levels among recipients of
C57BL/6J cecal microbes (r  0.49, p  0.04; Fig. 11B). How-
ever, RF39 did not show up as a taxa associated with TMAO
levels in the analyses looking across all four recipient groups
(r  0.11, p  0.4). Only one “NZW/LacJ characteristic” taxa
identified by LEfSe analysis of both cecal and fecal donor micro-
bial communities (Fig. 7) was associated with atherosclerosis
extent and TMAO levels. Proportions of the genus Dorea
within recipient feces (8 weeks) were inversely correlated with
both plasma TMAO levels and atherosclerosis extent (r 
FIGURE 9. Distribution of 10 identified donor characteristic taxa in cecum
of recipients at 20 weeks. A, 10 donor characteristic taxa (Fig. 7) were iden-
tified whose proportions in either cecum or feces remained indicative of the
donor, as described under “Results.” Shown here are the proportions of these
10 characteristic taxa observed at 20 weeks of age in cecal samples recovered
from the indicated recipient groups. B, left, bar graph illustrating the propor-
tions of the 10 donor characteristic taxa, which make up 6.8% of the compo-
sition of the fecal microbes within C57BL/6J Apoe/ recipient female mice
before antibiotic treatment. Right, the pie chart shows the proportions
among the 10 donor characteristic taxa in the C57BL/6J apoE/ recipient
female mice before antibiotic treatment.
FIGURE 10. Proportions of the genus Prevotella in feces are associated
with plasma TMAO plasma levels and aortic root atherosclerosis extent.
A and C, the proportion of Prevotella in fecal samples recovered from the
indicated 8-week-old recipient groups is plotted (y axis) versus plasma TMAO
levels (A) or aortic root atherosclerotic plaque level (C) (x axis), with each data
point representing mean  S.E. from n  12 mice. A positive correlation
(Spearman) is observed (r  0.44, p  0.0003) between Prevotella proportions
and TMAO levels across all four recipient groups, and between the proportion of
Prevotella and atherosclerosis extent among recipients provided the high cho-
line-supplemented diet (r  0.37, p  0.02). B, relative abundances of Prevotella
throughout the course of the study followed the same trend as the TMAO levels
in that the values started to converge by 16 weeks and at the end point.
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0.29, p  0.04, and r  0.21, p  0.04, for plasma TMAO
and atherosclerosis, respectively; Fig. 11C).
No other donor characteristic microbial taxa, as defined by our
criterion for observation in both cecum and feces (Fig. 7), showed
significant correlations with both atherosclerosis extent and
TMAO levels. However, some of the taxa that were identified as
donor characteristic in either feces or cecum, but not both (Fig. 7),
did show notable associations with either TMAO and/or athero-
sclerosis. For example, the recipient proportions (feces, 8 weeks) of
the taxa (order) RF32, whose abundance is characteristic of
C57BL/6J in donor cecal microbial analyses (Fig. 7A), were highly
positively correlated with plasma TMAO levels among all recipi-
ent groups (r  0.44, p  0.0003), and both borderline positively
associated with atherosclerosis extent for choline dietary groups
(r  0.32, p  0.05) and strongly inversely associated among low
choline (chow) recipient groups (r  0.40, p  0.009; all four
groups, r  0.07, p  0.5) (Fig. 12).
DISCUSSION
Over a century ago, Robert Koch put forth a series of postu-
lates to establish causality between a microbe and a disease
(11–13). Although not universally fulfilled in infectious disease
etiology, the conceptual framework they provide serves as a
guide for proving a causal relationship between microbial spe-
FIGURE 11. Examples of donor characteristic taxa that associate with plasma TMAO levels and atherosclerosis in recipients. The graphs in the left column
plot plasma TMAO concentrations on the x-axes, whereas graphs in the right column plot aortic atherosclerotic lesion extent on the x-axes of the indicated
recipient groups. All y-axes contain the relative abundance of the indicated donor characteristic taxa as identified from the LEfSe analysis (Fig. 7). Spearman
correlation coefficients and false discovery rate adjusted p values are shown. A, taxa Erysipelotrichaceae, characteristic (more abundant) of C57BL/6J donor
mice, is positively correlated with TMAO across all four recipient groups and with atherosclerosis extent for recipients of atherosclerosis-prone C57BL/6J cecal
microbes. B, taxa RF39, also characteristic of C57BL/6J donors, is positively correlated with both atherosclerosis extent (all recipients) and TMAO levels among
C57BL/6J recipient groups. C, proportions of the taxa Dorea, characteristic of NZW/LacJ donors, demonstrates negative associations with both plasma TMAO
levels and atherosclerosis extent across all recipient groups. Data points represent mean  S.E.
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cies and disease. In this regard, despite studies demonstrating
that the direct provision of a gut microbe-dependent product,
TMAO, can itself foster accelerated atherosclerosis develop-
ment and phenotypes (5, 6), and that dietary supplementation
with the nutrient precursors to TMAO, choline and carnitine,
similarly foster a pro-atherosclerotic phenotype in the pres-
ence, but not the absence, of intact gut microbiota and TMAO
formation (5, 6), no studies to date have directly demonstrated
transmission of atherosclerosis susceptibility by gut microbial
transplantation. The present studies provide, for the first time,
direct evidence that atherosclerosis susceptibility within a host
may be influenced by gut (cecal) microbial transplantation. The
studies thus fulfill an essential Koch’s postulate, demonstrating
that provision of microorganisms can cause or impact disease
phenotype when introduced into a recipient organism.
Recent studies have shown that intestinal microbes serve as
critical participants in development of complex metabolic pheno-
types such as obesity and insulin resistance, and that traits like
percentage of body fat and capacity for energy harvest are trans-
missible via inoculation of donor intestinal microbiota into recip-
ient mice (28, 29). We reasoned that at least a portion of the
differences in atherosclerosis susceptibility observed among
distinct inbred strains of mice could similarly arise from their
distinct microbial communities and ability to generate TMAO,
a possibility further suggested by the striking association
observed between atherosclerosis plaque development and
plasma TMAO levels among different inbred strains of mice. As
part of our study design, we selected relative extremes in the
spectrum of atherosclerosis susceptibility, using C57BL/6J
mice as an atherosclerosis-prone strain, and NZW/LacJ mice as
an atherosclerosis-resistant strain to serve as microbial donors.
By first suppressing endogenous microbes in recipients with a
mixture of poorly absorbed oral antibiotics, we were able to
show that recipients receiving cecal microbial suspensions from
the atherosclerosis-prone donors demonstrated enhanced ather-
osclerosis relative to recipients receiving cecal microbes from ath-
erosclerosis-resistantdonors.Interestingly,theincrease inathero-
sclerosis was only observed in the presence of a high choline
diet, where differences in TMA and TMAO plasma levels, at
least initially in the post-transplantation period, were observed.
Thus, both atherosclerosis extent and choline diet-dependent
increases in TMA and TMAO were each shown to be, in part,
transmissible traits, although differences in TMA/TMAO pro-
duction were relatively modest and not durable. Also of note,
the recipients of the atherosclerosis-resistant NZW/LacJ cecal
microbes failed to demonstrate increase in atherosclerosis on
the high choline diet, despite a significant elevation in TMAO gen-
eration. We speculate that the mechanism for this may involve
transmission of protective “anti-atherosclerotic” microbial taxa
from the atherosclerosis-resistant donor with the transplanta-
tion. It should also be noted that the host (Apoe/) genetic
background of the recipient may also contribute to choline
diet-induced changes in plasma TMA/TMAO upon coloniza-
tion with donor microbiota. Importantly, differences in ather-
osclerosis observed in the recipient mice following cecal micro-
bial transplantation were not a result of changes in lipids/
lipoprotein levels, or changes in other recognized risk factors
for atherosclerosis (e.g. glycemic control, adiposity). Collec-
tively, the present studies show that atherosclerosis susceptibil-
ity in the mouse model is influenced by a dynamic interaction
between genetics, environment, and gut microbiota, which are
uniquely and anatomically situated at the interface between these
factors (Fig. 13). Indeed, gut microbiota serve as a filter of our
largest environmental exposure, the food we eat, and are influ-
enced, in turn, by both host genetics and dietary nutrients (Fig. 13).
When designing the present studies, although not necessary
conceptually to prove microbial transmission of phenotype, we
would have ideally liked to have used germ-free mice as recip-
FIGURE 12. Example of donor characteristic taxa whose proportions are
associated with plasma TMAO levels and atherosclerosis extent in recip-
ients. Proportions of order RF32 (Alphaproteobacteria class), noted as a
characteristic taxa of C57BL/6J donors from cecal samples, are associated
positively with TMAO across all four recipient groups (top) and with athero-
sclerosis among the two recipient groups on the choline diet (bottom). Data
points represent mean  S.E.
FIGURE 13. Summary schematic illustrating reciprocal interactions
between genetics, environment, and intestinal microbiota, all of which
impact on atherosclerosis susceptibility.
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ients to increase the odds of seeing a positive outcome. How-
ever, germ-free mouse genotypes suitable for atherosclerosis
studies (e.g. Apoe/) were not available to us at the time. Dif-
ficulty in maintaining new (non-native) microbiota in recipient
mice, whether germ-free or those in which gut microbiota sup-
pression was initially performed with oral mixture of poorly
absorbed antibiotics, has been reported in other studies (30–32).
We therefore were concerned that the duration of successful
transplantation of donor microbial community structure and
function into the recipients might not be sufficient to permit
observation of transmissibility of the desired traits: atherosclerosis
and choline diet-dependent plasma TMA and TMAO levels.
However, our results clearly show that under the experimental
conditions used, we were able to functionally demonstrate choline
diet-dependent enhancement in atherosclerosis. Further, choline
diet-induced differences in plasma TMA and TMAO levels were
observed, albeit only transiently. Interestingly, enhanced athero-
sclerosis was not observed in recipient mice that received the ath-
erosclerosis-prone cecal microbes when maintained on a relatively
low choline content diet, yet enhanced atherosclerosis was
observed to be a transmissible trait in the recipient mice that both
received the atherosclerosis-prone cecal microbes and were main-
tained on a high choline diet. Microbiota composition analyses in
parallel revealed that multiple characteristic taxonomic features of
the donors were transmitted to the recipients, and although the
durability of these features became attenuated over time, donor
characteristic taxa in both cecal and fecal communities remained
visible within the recipients in both dietary arms throughout the
study time course.
We think that several additional points are also worth noting.
First, it is interesting that the differences in choline diet-in-
duced enhancement in TMAO levels were not durable beyond
the initial period after cecal microbial transplantation, yet cho-
line diet-enhanced atherosclerosis was observed at the end of
study duration. Other atherosclerosis studies have shown that
there exist windows of time in mouse models where exposure to
a trait may influence long term susceptibility for atherosclerosis
development. For example, selective depletion of neutrophil
levels in Apoe/ mice for a relatively brief window of time,
during the first 4 weeks of a high fat diet, but not after 3 or 11
months of a high fat diet, significantly inhibits long term athero-
sclerosis development during chronic dietary exposure (33).
Similarly, recent studies by Blaser and colleagues (34) show that
affecting microbiota in early windows of critical development
can affect metabolism long term. Specifically, they have identi-
fied several taxa transiently disrupted after low-dose penicillin
administration at mouse weaning age to be linked to persistent
metabolic alterations such as enhanced dietary-induced fat
mass accumulation and decreased intestinal-based immunity
(34). In our own studies, we also observed more transient
changes in microbiota early on that were not sustained to the
study end point (e.g. differences in Allobaculum, Bacteroides,
and Prevotella), and yet we still observed divergent functional
outcomes. It is thus possible that the window of relatively
reduced TMA/TMAO exposure in the recipient mice that were
inoculated with NZW/LacJ cecal microbes and placed on the
high choline diet was sufficient to influence overall atheroscle-
rosis development. It is of course also possible that other cho-
line diet-induced microbial traits were transplanted, yet not
monitored, that contributed to the outcome. Indeed, the pres-
ent study design does not exclude the possibility that factors
alternative or in addition to TMA and TMAO participate in the
enhanced choline diet-induced atherosclerosis observed (or
suppression of atherosclerosis, in the case of transplant from
NZW/LacJ). In addition, it is worth noting that cecal contents
consist of not only microbes but also food matter and a host of
unknown, potentially biochemically active microbial products.
Mass spectrometry analyses of the TMA and TMAO content of
the cecal slurries used for gavages showed that the total content
of TMA  TMAO was negligible (“Experimental Procedures”).
Whether other unmeasured factors beyond microbes were
transferred with the gavages and might impact atherosclerosis
susceptibility remains unknown. However, if such a factor(s)
exists, it too is transmissible (or influenced by something trans-
missible) with cecal luminal contents used in the microbial
transplantation studies, and is choline diet-dependent.
The present studies not only affirm a contributory role, at
least in part, of gut microbiota to atherosclerosis susceptibility,
but also suggest that microbe-targeted therapies may be of rel-
evance to the treatment of atherosclerosis. Although few ther-
apies targeting gut microbiota have translated into clinical use,
the concept has been in existence for quite some time. Shifting
gut microbial composition in humans with the aim of changing
the course of disease was reported in 1958 by surgeons who
treated patients suffering from antibiotic-induced diarrhea
colitis by introducing microbiota from healthy donors (35).
There has been a resurgence in interest in the potential of fecal
transplantation for the treatment of recurrent Clostridium dif-
ficile infection because it was recently reported to be superior to
administration of antibiotics (vancomycin) in direct head-to-
head comparison studies (36). Remarkably, recent clinical stud-
ies have also shown that even complex metabolic traits such as
insulin sensitivity may be influenced in subjects with microbial
transplantation because subjects with metabolic syndrome can
show improvement in insulin sensitivity by microbial (fecal)
transplantation from lean healthy donors (37). The present
studies raise the potential to apply gut microbiome-altering
therapies for atherosclerotic heart disease. Although there are
numerous challenges that need to be overcome before this can
become a reality, the prospects are exciting.
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Note Added in Proof—Fig. 3A was incorrectly labeled “0.07% choline”
in the version of this article that was published as a Paper in Press on
December 30, 2014. The correct label, “1.06% choline,” is now shown
above the bottom right corner image.
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17. Köhler, C. (2007) Allograft inflammatory factor-1/Ionized calcium-bind-
ing adapter molecule 1 is specifically expressed by most subpopulations of
macrophages and spermatids in testis. Cell Tissue Res. 330, 291–302
18. Hamady, M., Walker, J. J., Harris, J. K., Gold, N. J., and Knight, R. (2008)
Error-correcting barcoded primers for pyrosequencing hundreds of sam-
ples in multiplex. Nat. Methods 5, 235–237
19. Caporaso, J. G., Lauber, C. L., Walters, W. A., Berg-Lyons, D., Huntley, J.,
Fierer, N., Owens, S. M., Betley, J., Fraser, L., Bauer, M., Gormley, N.,
Gilbert, J. A., Smith, G., and Knight, R. (2012) Ultra-high-throughput mi-
crobial community analysis on the Illumina HiSeq and MiSeq platforms.
ISME J. 6, 1621–1624
20. Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D.,
Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., Huttley,
G. A., Kelley, S. T., Knights, D., Koenig, J. E., Ley, R. E., Lozupone, C. A.,
McDonald, D., Muegge, B. D., Pirrung, M., Reeder, J., Sevinsky, J. R., Turn-
baugh, P. J., Walters, W. A., Widmann, J., Yatsunenko, T., Zaneveld, J., and
Knight, R. (2010) QIIME allows analysis of high-throughput community
sequencing data. Nat. Methods 7, 335–336
21. Bokulich, N. A., Subramanian, S., Faith, J. J., Gevers, D., Gordon, J. I.,
Knight, R., Mills, D. A., and Caporaso, J. G. (2013) Quality-filtering vastly
improves diversity estimates from Illumina amplicon sequencing. Nat.
Methods 10, 57–59
22. Edgar, R. C. (2010) Search and clustering orders of magnitude faster than
BLAST. Bioinformatics 26, 2460 –2461
23. McDonald, D., Price, M. N., Goodrich, J., Nawrocki, E. P., DeSantis, T. Z.,
Probst, A., Andersen, G. L., Knight, R., and Hugenholtz, P. (2012) An
improved Greengenes taxonomy with explicit ranks for ecological and
evolutionary analyses of bacteria and archaea. ISME J. 6, 610 – 618
24. Lozupone, C. A., and Knight, R. (2008) Species divergence and the mea-
surement of microbial diversity. FEMS Microbiol. Rev. 32, 557–578
25. Pirrung, M., Kennedy, R., Caporaso, J. G., Stombaugh, J., Wendel, D., and
Knight, R. (2011) TopiaryExplorer: visualizing large phylogenetic trees
with environmental metadata. Bioinformatics 27, 3067–3069
26. Segata, N., Izard, J., Waldron, L., Gevers, D., Miropolsky, L., Garrett, W. S.,
and Huttenhower, C. (2011) Metagenomic biomarker discovery and ex-
planation. Genome Biol. 12, R60
27. Rooks, M. G., Veiga, P., Wardwell-Scott, L. H., Tickle, T., Segata, N., Mi-
chaud, M., Gallini, C. A., Beal, C., van Hylckama-Vlieg, J. E., Ballal, S. A.,
Morgan, X. C., Glickman, J. N., Gevers, D., Huttenhower, C., and Garrett,
W. S. (2014) Gut microbiome composition and function in experimental
colitis during active disease and treatment-induced remission. ISME J. 8,
1403–1417
28. Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R.,
and Gordon, J. I. (2006) An obesity-associated gut microbiome with in-
creased capacity for energy harvest. Nature 444, 1027–1031
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